Atlas Trials

Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)

Clinical trial NCT01708850 · COMPLETED

Trial details

NCT number
NCT01708850
Sponsor
London Health Sciences Centre
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
NeoplasmCentral Venous Catheter Thrombosis
Start date
2012-11-01
Primary completion
2016-05-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.